Liquidia Corporation

Liquidia Corp is a nanotechnology-based biopharmaceutical company engaged in the development and commercialisation of human therapeutics. It operates mainly in the US, specialising in products developed using PRINT technology to transform the lives of patients. Liquidia Corporation is immersed in the biotechnology sector, focusing on specialised drug delivery systems. Working through its subsidiaries, Liquidia’s services include the creation of precisely engineered particles for the systemic or local delivery of a wide variety of drugs. Stay up to date on the share price of LQDA by adding it to your eToro watchlist.